Detalhe da pesquisa
1.
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Proc Natl Acad Sci U S A
; 119(21): e2200413119, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576468
2.
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
J Exp Med
; 221(2)2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175961
3.
Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets.
Cell Rep Med
; 4(1): 100894, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652906
4.
Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia.
J Interferon Cytokine Res
; 43(9): 379-393, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253131
5.
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
J Exp Med
; 219(11)2022 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112363
6.
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.
Res Sq
; 2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35043109
7.
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Sci Immunol
; 6(62)2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413139